NCT04504942Phase 2Completed

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Study sponsor: CytoDyn, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2021-11-07Actual
Enrollment · participants16Actual
Source updated2026-01-23Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview